Researchers conducted a clinical trial to see if a specific team-based discharge planning program could improve outcomes for patients with Inflammatory Bowel Disease. The study included 90 inpatients who were randomly assigned to either receive the new structured program or continue with standard hospital care. Participants were followed for 30 days after leaving the hospital to measure their readiness for discharge and overall health-related quality of life.
The results showed that the group receiving the structured program had significantly higher discharge readiness scores than the control group. Additionally, the quality of discharge teaching was significantly better in the intervention group. Patients in the new program also showed a greater improvement in their health-related quality of life compared to those receiving standard care.
No safety concerns were reported, as there were no adverse events or discontinuations noted in the study. While these findings are encouraging, the small number of participants means the evidence is limited. Readers should understand that this study suggests potential benefits but does not yet prove that this specific program is ready for universal use without further research.
